Remote Monitoring and Behavioral Economics in Managing Heart Failure in Patients Discharged From the Hospital: A Randomized Clinical Trial

May 9, 2022

JAMA Internal Medicine

Read the full article

Authors

David A. Asch, Andrea B. Troxel, Lee R. Goldberg, Monique S. Tanna, Shivan J. Mehta, Laurie A. Norton, Jingsan Zhu, Lauren G. Iannotte, Tamar Klaiman, Yuqing Lin, Louise B. Russell, Kevin G. Volpp

CHIBE Experts

Research Areas

Does counting change what counts? Quantification fixation biases decision-making

PNAS

November 12, 2024
Repeal of Subminimum Wages and Social Determinants of Health Among People With Disabilities

JAMA Health Forum

November 1, 2024
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl

JAMA Network Open

September 27, 2024
Implementation of a Secure Firearm Storage Program in Pediatric Primary Care: A Cluster Randomized Trial

JAMA Pediatrics

September 19, 2024
Acceptability, Feasibility, and Appropriateness of the B-OK Bottles as an Implementation Strategy for Treatment Adherence Support by Medical Case Managers

Global Implementation Research and Applications

September 17, 2024
Skepticism Calibration Disorder—The New Public Health Crisis

JAMA Network Open

September 4, 2024
Emergency Medicaid enrollment after traumatic injury predicts long-term health care utilization

Journal of Trauma and Acute Care Surgery

September 3, 2024
Can nudges be leveraged to enhance diversity in organizations? A systematic review

Current Opinion in Psychology

August 30, 2024
Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments

JAMA Network

August 19, 2024
The NUDGE Framework: Application to Address Behavioral Barriers to Antiretroviral Therapy in Adolescents Living With HIV in Eswatini

AIDS Education and Prevention

August 1, 2024
Using machine learning to unveil relevant predictors of adherence to recommended health-protective behaviors during the COVID-19 pandemic in Denmark

International Association of Applied Psychology

June 8, 2024
Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans

JAMA Network

June 6, 2024